Clinical Trial: A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab sc Injection in Italy

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214753) titled 'A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab sc Injection in Italy' on Oct. 06.

Brief Summary: This is an observational, multicenter, prospective study on patients with severe eosinophilic asthma treated with benralizumab aimed at evaluating the achievement of partial and complete clinical remission.

Study Start Date: Dec. 19

Study Type: OBSERVATIONAL

Condition: Severe Eosinophilic Asthma

Intervention: BIOLOGICAL: benralizumab

30mg s.c. as per SmPC

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....